Dipyridamole-Induced Epistaxis
- 1 May 1986
- journal article
- research article
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 95 (3) , 302-303
- https://doi.org/10.1177/000348948609500318
Abstract
The case history of a patient treated with dipyridamole who developed severe epistaxis, accompanied by alteration of the platelet aggregation tests, is presented. The bleeding did not respond to local therapy and stopped only after discontinuation of the drug and normalization of the platelet aggregation. Hemorrhage, especially in elderly patients, should be considered as a possible complication of dipyridamole administration.Keywords
This publication has 13 references indexed in Scilit:
- Dipyridamole Inhibits Platelet Aggregation in Whole BloodThrombosis and Haemostasis, 1983
- Extensive Pharyngeal Hemorrhage Induced by DipyridamoleActa Haematologica, 1981
- Hemorrhage as a Complication of Dipyridamole TherapySouthern Medical Journal, 1979
- Antiplatelet TherapyNew England Journal of Medicine, 1978
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- Effects of sulphinpyrazone and dipyridamole on capillary bleeding time in manThrombosis Research, 1977
- Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve ReplacementNew England Journal of Medicine, 1971
- The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′:5′-cyclic monophosphate in plateletsBiochemical Journal, 1971
- Effect of a Pyrimidopyrimidine Derivative on Thrombus Formation in the RabbitNature, 1965
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965